Back to SNDX
Hennion & Walsh Asset Management, Inc. → SNDX
Hennion & Walsh Asset Management, Inc. SNDX Position History
Syndax Pharmaceuticals, Inc. • Healthcare
Quarters held
5
Latest value
$7.3M
Q3 2026
Peak value
$7.5M
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $842K |
| Q4 2025 | $3.9M |
| Q1 2026 | $5M |
| Q2 2026 | $7.5M |
| Q3 2026 | $7.3M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $7.3M | 386.4K | — | — |
| Q2 2026 | $7.5M | 342.9K | — | — |
| Q1 2026 | $5M | 214.8K | — | — |
| Q4 2025 | $3.9M | 183.8K | — | — |
| Q3 2025 | $842K | 54.7K | — | — |
Other funds holding SNDX
$123.7M
$123.7M
$118.9M
$116.1M
$114.7M
$114.2M
$114.2M
$111.4M